Trademark applications and grants for Heptares Therapeutics L T D. Heptares Therapeutics L T D has 3 trademark applications. The latest application filed is for "HEPTARES"
Patent Application | Date |
---|---|
CGRP ANTAGONIST COMPOUNDS 20220306651 - 17/617873 Brown; Giles Albert ;   et al. | 2022-09-29 |
OXIME COMPOUNDS AS AGONISTS OF THE MUSCARINIC M1 AND/OR M4 RECEPTOR 20220298133 - 17/551976 Brown; Giles Albert ;   et al. | 2022-09-22 |
CGRP ANTAGONIST COMPOUNDS 20220251110 - 17/617851 Brown; Giles Albert ;   et al. | 2022-08-11 |
SUBSTITUTED CYCLOHEXANES AS MUSCARINIC M1 RECEPTOR AND/OR M4 RECEPTOR AGONISTS 20220213034 - 17/306390 Brown; Giles Albert ;   et al. | 2022-07-07 |
OXEXIN 1 RECEPTOR ANTAGONISTS 20220098165 - 17/426301 Brown; Giles Albert ;   et al. | 2022-03-31 |
Mark Image Registration | Serial | Trademark Application Date |
---|---|
"HEPTARES" 5239010 86577541 |
HEPTARES 2015-03-26 |
"STAR" 4891860 86577513 |
STAR 2015-03-26 |
"STAR" 79084545 |
STAR 2010-05-21 |
NCAGE Code | U0RW3 | HEPTARES THERAPEUTICS LIMITED |
CAGE Code | U0RW3 | HEPTARES THERAPEUTICS LIMITED |
S.A.M. Registration | U0RW3 [210011328] | HEPTARES THERAPEUTICS LIMITED |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.